The impact of real estate investments on end-of-life care for Alzheimer's patients in nursing homes

Who could benefit from this research

What this research studies

This research investigates how investments from real estate investment trusts (REITs) in nursing homes affect the quality of end-of-life care for residents suffering from Alzheimer's disease and related dementias (ADRD). It aims to analyze the relationship between REIT ownership and the care provided to these vulnerable patients, given that a significant portion of nursing home residents have ADRD. The study will utilize data from nursing homes across the United States to assess care quality metrics and outcomes for residents with ADRD. By understanding these dynamics, the research seeks to inform policymakers and improve care standards in nursing homes.

Why it matters

Where this research is happening

• Weill Medical Coll of Cornell Univ
  New York, United States Active

Researchers

• Principal investigator: Unruh, Mark Aaron — Weill Medical Coll of Cornell Univ
• Study coordinator: Unruh, Mark Aaron

Related research

Other NIH-funded projects on the same topics.

• Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model

  Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.

  NIH research Nathan S. Kline Institute for Psych Res · Orangeburg, United States · NIH-11627965

• Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients

  A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.

  NIH research Weill Medical Coll of Cornell Univ · New York, United States · NIH-11627145

• Non-invasive tears biomarker for early Alzheimer's in LMICs

  A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

  NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

• Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s

  A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.

  NIH research Weill Medical Coll of Cornell Univ · New York, United States · NIH-11622616

• Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health

  Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.

  NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11622615

• Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues

  Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.

  NIH research University of Delaware · Newark, UNITED STATES · NIH-11619072

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.